Association of Polypharmacy and Potentially Inappropriate Medications With Outcomes in Older Adults With DLBCL: A Population Study
Polypharmacy and PIMs are associated with an increased relative risk of mortality and health care utilization among older adults with DLBCL undergoing treatment, independent of frailty and comorbidity.
Authors
- Inna Y. Gong (ORCID: https://orcid.org/0000-0001-9306-2945)
- Shabbir M.H. Alibhai (ORCID: https://orcid.org/0000-0001-7815-6046)
- Zharmaine Ante
- Clark DuMontier (ORCID: https://orcid.org/0000-0003-2582-7816)
- Matthew C. Cheung (ORCID: https://orcid.org/0000-0003-3193-5872)
- Anca Prica
- Andrew Calzavara
- Jane A. Driver (ORCID: https://orcid.org/0000-0001-9759-4607)
- Tammy T. Hshieh (ORCID: https://orcid.org/0000-0001-8673-6681)
- Lee Mozessohn (ORCID: https://orcid.org/0000-0003-3436-3849)
- Abi Vijenthira (ORCID: https://orcid.org/0000-0001-5369-1501)
- Gregory Alan Abel (ORCID: https://orcid.org/0000-0003-1100-2813)
Institutions
- Brigham and Women's Hospital (US)
- Sunnybrook Health Science Centre (CA)
- University Health Network (CA)
- Harvard University (US)
- University of Toronto (CA)
- Health Sciences Centre (CA)
- Princess Margaret Cancer Centre (CA)
- Geriatric Research Education and Clinical Center (US)
- Dana-Farber Cancer Institute (US)
- Institute for Clinical Evaluative Sciences (CA)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-06-27
- DOI
- https://doi.org/10.6004/jnccn.2025.7029
- Citations
- 1
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 1.52